What is the address of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG?

The registered office of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is located at Koklenberghof 11 box 301, 9100 Sint-Niklaas.

Is DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG still active?

Yes. According to the CBE (1 October 2026) DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is active, legal situation “Normale toestand”, started on 8 February 2022.

Is DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG registered on Peppol?

Yes, DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is registered on the Peppol network with ID 0208:0781747249.

What is the enterprise number of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG?

The enterprise number of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is BE0781747249.

When was DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG founded?

DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG was founded on 8 February 2022.

Who are the directors of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG?

According to the 2025 annual accounts, the directors of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG are: DASHTY HUSEIN.

Is DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 February 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG make in 2025?

DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG posted a profit after taxes of € 205,619 in financial year 2025.

What is the revenue of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG?

As a small company, DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 294,738.

DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG (Private Limited)

Dossier DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG, printed on 1 October 2026 from databakkes.be/en/0781747249/dr-d-husein-endocrinoloog-diabetoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG from Sint-Niklaas, company number BE0781747249, closed financial year 2025 with a result of € 205,619 after tax. For that financial year DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG recorded a gross margin of € 294,738 and equity of € 448,534. Compared with financial year 2024, the result moved from € 188,245 to € 205,619. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 448,534

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 205,619

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 501,416

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 193,864 paid out

94 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,153

▲ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,016

▲ € 10,699 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 106,170 Gross margin 2022: € 106,170 First fiscal year in the series	€ 253,010 Gross margin 2023: € 253,010 ▲ 138% vs 2022 (€ 106,170) Favourable step	€ 260,230 Gross margin 2024: € 260,230 ▲ 3% vs 2023 (€ 253,010) Favourable step	€ 294,738 Gross margin 2025: € 294,738 ▲ 13% vs 2024 (€ 260,230) Favourable step	▲ 13%
Profit after taxes	€ 75,400 Profit after taxes 2022: € 75,400 First fiscal year in the series	€ 173,767 Profit after taxes 2023: € 173,767 ▲ 130% vs 2022 (€ 75,400) Favourable step	€ 188,245 Profit after taxes 2024: € 188,245 ▲ 8% vs 2023 (€ 173,767) Favourable step	€ 205,619 Profit after taxes 2025: € 205,619 ▲ 9% vs 2024 (€ 188,245) Favourable step	▲ 9%
Equity	€ 75,600 Equity 2022: € 75,600 First fiscal year in the series	€ 248,534 Equity 2023: € 248,534 ▲ 229% vs 2022 (€ 75,600) Favourable step	€ 436,779 Equity 2024: € 436,779 ▲ 76% vs 2023 (€ 248,534) Favourable step	€ 448,534 Equity 2025: € 448,534 ▲ 3% vs 2024 (€ 436,779) Favourable step	▲ 3%
Total debts	€ 56,208 Total debts 2022: € 56,208 First fiscal year in the series	€ 23,014 Total debts 2023: € 23,014 ▼ 59% vs 2022 (€ 56,208) Favourable step	€ 5,999 Total debts 2024: € 5,999 ▼ 74% vs 2023 (€ 23,014) Favourable step	€ 73,789 Total debts 2025: € 73,789 ▲ € 67,789 vs 2024 (€ 5,999) Unfavourable step	▲ € 67,789
Cash	€ 128,011 Cash 2022: € 128,011 First fiscal year in the series	€ 263,881 Cash 2023: € 263,881 ▲ 106% vs 2022 (€ 128,011) Favourable step	€ 428,256 Cash 2024: € 428,256 ▲ 62% vs 2023 (€ 263,881) Favourable step	€ 501,416 Cash 2025: € 501,416 ▲ 17% vs 2024 (€ 428,256) Favourable step	▲ 17%
Retained profit	€ 74,600 Retained profit 2022: € 74,600 First fiscal year in the series	€ 247,534 Retained profit 2023: € 247,534 ▲ 232% vs 2022 (€ 74,600) Favourable step	€ 435,779 Retained profit 2024: € 435,779 ▲ 76% vs 2023 (€ 247,534) Favourable step	€ 447,534 Retained profit 2025: € 447,534 ▲ 3% vs 2024 (€ 435,779) Favourable step	▲ 3%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 833) Unchanged	€ 193,864 Dividend 2025: € 193,864 Unchanged (€ 0) Unchanged
Balance sheet total	€ 131,808 Balance sheet total 2022: € 131,808 First fiscal year in the series	€ 271,548 Balance sheet total 2023: € 271,548 ▲ 106% vs 2022 (€ 131,808) Unchanged	€ 442,778 Balance sheet total 2024: € 442,778 ▲ 63% vs 2023 (€ 271,548) Unchanged	€ 522,323 Balance sheet total 2025: € 522,323 ▲ 18% vs 2024 (€ 442,778) Unchanged	▲ 18%

Key figures of DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG?

What happened at DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 205,619 (▲ 9% vs 2024). Source: NBB ↗
Feb 8, 2022 New establishment in Sint-Niklaas. KBO
Feb 8, 2022 Start of the company according to the CBE. KBO

In short

From € 75,400 profit in 2022 to € 205,619 profit in 2025.

Paid € 249,831 in corporate taxes since 2022.

Best year ever: 2025, with € 205,619 profit.

Paid out € 195,497 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG? We notify you, reason included.

Follow DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

DASHTY HUSEIN

DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG

Behind DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG is DASHTY HUSEIN.

See the full network in the app

Directors

According to the 2025 annual accounts

DASHTY HUSEIN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Koklenberghof 11 box 301

9100 Sint-Niklaas

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Cédric Van Aelst Kinesitherapie

€ 72,310 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0781.747.249
VAT number: BE 0781.747.249
Registered office: Koklenberghof 11 bus 301, 9100 Sint-Niklaas
Names & denominations: DR. D. HUSEIN, ENDOCRINOLOOG-DIABETOLOOG · DR. D. HUSEIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 February 2022
Peppol: Active · Active since 31 Oct 2023

View on CBE Public ↗ Annual accounts (NBB) ↗